南京科佰生物科技有限公司

主營產(chǎn)品: atcc代理,ATCC細(xì)胞系,ATCC細(xì)胞株,ATCC細(xì)胞庫購買

11

聯(lián)系電話

18066071954

您現(xiàn)在的位置: 南京科佰生物科技有限公司>>藥靶細(xì)胞株>>kinase激酶細(xì)胞株>> CBP73166EGFR WT (EGF Dependent)/BaF3

公司信息

聯(lián)人:
蔣經(jīng)理
話:
4008750250
機(jī):
18066071954
真:
址:
南京市棲霞區(qū)緯地路9號
編:
210000
個(gè)化:
www.co-bioer.com
網(wǎng)址:
www.cobioer.com/
鋪:
http://true-witness.com/st281842/
給他留言
CBP73166EGFR WT (EGF Dependent)/BaF3
EGFR WT (EGF Dependent)/BaF3
參考價(jià) 面議
具體成交價(jià)以合同協(xié)議為準(zhǔn)
  • 型號 CBP73166
  • 品牌 cobioer/科佰生物
  • 廠商性質(zhì) 代理商
  • 所在地 南京市

更新時(shí)間:2023-10-25 13:40:30瀏覽次數(shù):1093

聯(lián)系我們時(shí)請說明是化工儀器網(wǎng)上看到的信息,謝謝!

【簡單介紹】
供貨周期 現(xiàn)貨 規(guī)格 T-25 Flask
貨號 CBP73166 應(yīng)用領(lǐng)域 生物產(chǎn)業(yè)
主要用途 僅限科研使用
EGFR WT (EGF Dependent)/BaF3,母細(xì)胞:BaF3,凍存條件:90% FBS+10% DMSO
【詳細(xì)說明】
CBP73166
I. Introduction

Cell Line Name:

EGFR WT (EGF Dependent)/BaF3

Host Cell:

BA/F3

Stability:16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)

Application:

Anti-proliferation assay and PD assay

Freeze Medium:

90% FBS+10% DMSO

Complete Culture Medium:

RPMI-1640+10%FBS+100ng/ml EGF

Mycoplasma Status:

Negative


II.Background

EGFR is widely recognized for its importance in cancer. Amplification and mutations have been shown to be driving events in many cancer types. Its role in non-small cell lung cancer, glioblastoma and basal-like breast cancers has spurred many research and drug development efforts. Tyrosine kinase inhibitors have shown efficacy in EGFR amplfied tumors, most notably gefitinib and erlotinib. Mutations in EGFR have been shown to confer resistance to these drugs, particularly the variant T790M, which has been functionally characterized as a resistance marker for both of these drugs. The later generation TKI's have seen some success in treating these resistant cases, and targeted sequencing of the EGFR locus has become a common practice in treatment of non-small cell lung cancer. Overproduction of ligands is another possible mechanism of activation of EGFR. ERBB ligands include EGF, TGF-a, AREG, EPG, BTC, HB-EGF, EPR and NRG1-4 (for detailed information please refer to the respective ligand section). In ligand-activated cancers, Cetuximab appears to be more effective than tyrosine-kinase inhibitors.


III. Representative Data

1.WB of  EGFR WT (EGF Dependent)/BaF3

CBP73166 WB.png


2. Anti-proliferation assay

CBP73166 新.jpg


Figure 2. CTG Proliferation Assay of EGFR WT(EGF Dependent) BaF3 cells (C16).







產(chǎn)品對比 產(chǎn)品對比 二維碼

掃一掃訪問手機(jī)商鋪

對比框

在線留言